Spots Global Cancer Trial Database for Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
Official Title: Phase II Study of Bryostatin-1 in Metastatic Renal Cell Carcinoma(Summary Last Modified 8/1999)
Study ID: NCT00003968
Conditions
Interventions
Study Description
Brief Summary: Phase II trial to study the effectiveness of bryostatin 1 in treating patients who have metastatic kidney cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
Detailed Description: OBJECTIVES: I. Determine the objective response rate to bryostatin 1 in patients with advanced renal cell carcinoma. II. Assess the toxicities of this treatment regimen in this patient population. III. Determine the time to disease progression in patients receiving this treatment regimen. IV. Determine the overall survival of this patient population treated with this regimen. OUTLINE: Patients receive bryostatin 1 IV over 1 hour on days 1, 8, and 15. Treatment continues every 4 weeks in the absence of unacceptable toxicity or disease progresssion. Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hunterdon Regional Cancer Center, Flemington, New Jersey, United States
Kimball Medical Center, Lakewood, New Jersey, United States
South Jersey Hospital - Millville, Millville, New Jersey, United States
Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County, Mount Holly, New Jersey, United States
Riverview Medical Center, Red Bank, New Jersey, United States
Community Medical Center, Toms River, New Jersey, United States
St. Francis Medical Center, Trenton, New Jersey, United States
Bon Secours-Holy Family Health System, Altoona, Pennsylvania, United States
Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States
Pinnacle Health Hospitals, Harrisburg, Pennsylvania, United States
Conemaugh Memorial Hospital, Johnstown, Pennsylvania, United States
Saint Mary Medical Center, Langhorne, Pennsylvania, United States
North Penn Hospital, Lansdale, Pennsylvania, United States
Paoli Memorial Hospital, Paoli, Pennsylvania, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Pottstown Memorial Regional Cancer Center, Pottstown, Pennsylvania, United States
Reading Hospital and Medical Center, Reading, Pennsylvania, United States
Contact Details
Name: Naomi S. Balzer-Haas, MD
Affiliation: Fox Chase Cancer Center
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
